Pipeline

We are dedicated to pushing the boundaries of pharmaceutical science to improve patient outcomes. Our development pipeline showcases a diverse array of innovative drug formulations, primarily focusing on in-situ forming implants that offer extended drug release for chronic conditions.
 
Our pipeline table below details the stages of development for our most promising projects, ranging from pre-formulation and primary reviews to advanced clinical phases. Each project reflects our commitment to addressing unmet medical needs through targeted, sustained-release therapies that enhance patient compliance and quality of life.
 
We continuously update our pipeline to reflect our latest research findings and development milestones, ensuring transparency and engagement with our stakeholders.
Our Pipeline Stages

  • Pre-Formulation

  • Formulation

  • Pre-Clinical

  • Clinical

  • Left Side: Product features (Therapeutic Area | Product Candidate | Indication)

  • Right Side: Current Stage

Our Pipeline

Endocrine | Octavarus® (Octreotide 3-Months Depot) | Acromegally GEP-NET PLD

Formulation

Gynecology / Oncology | Leuprorelin Acetate (2-months Depot) | Breast Cancer, Prostate Cancer, Endometriosis

Pre-Formulation

Antipsychotic | Risperidone (1-month Depot) | Schizophrenia/ Bi Polar Disorder

Pre-Formulation

Oncology | Granisetron (2-Weeks Depot) | Nausea & Vomiting Following Chemotherapy & Radiotherapy

Pre-Formulation

Gynecology / Oncology | Goserelin | Breast Cancer, Prostate Cancer, Endometriosis

Pre-Formulation

Scroll to Top